SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001493152-19-013510
Filing Date
2019-08-29
Accepted
2019-08-29 17:25:26
Documents
33
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form6-ka.htm 6-K/A 353447
  Complete submission text file 0001493152-19-013510.txt   1328522

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE vblt-20190630.xml EX-101.INS 117574
3 XBRL SCHEMA FILE vblt-20190630.xsd EX-101.SCH 26837
4 XBRL CALCULATION FILE vblt-20190630_cal.xml EX-101.CAL 40198
5 XBRL DEFINITION FILE vblt-20190630_def.xml EX-101.DEF 38984
6 XBRL LABEL FILE vblt-20190630_lab.xml EX-101.LAB 159022
7 XBRL PRESENTATION FILE vblt-20190630_pre.xml EX-101.PRE 96275
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-36581 | Film No.: 191067311
SIC: 2834 Pharmaceutical Preparations